MS
KLRS

Maven Securities’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History

Maven Securities’s Portfolio KLRS Stock Details KLRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-31,981
Closed -$2.5M – 621
2023
Q2 		$2.5M Buy
+31,981
New +$2.5M 0.04% 71
2021
Q1 		– Sell
-865
Closed -$799K – 1065
2020
Q4 		$799K Buy
+865
New +$799K 0.08% 264